Spaventi R - Search Results

1

Expression of erbB-3 protein in colorectal adenocarcinoma: correlation with poor survival.

Kapitanović S, Radosević S, Slade N, Kapitanović M, Andelinović S, Ferencić Z, Tavassoli M, Spaventi S, Pavelić K, Spaventi R. Kapitanović S, et al. Among authors: spaventi s, spaventi r. J Cancer Res Clin Oncol. 2000 Apr;126(4):205-11. doi: 10.1007/s004320050034. J Cancer Res Clin Oncol. 2000. PMID: 10782893

2

Loss of heterozygosity testing using real-time PCR analysis of single nucleotide polymorphisms.

Cacev T, Jokić M, Spaventi R, Pavelić K, Kapitanović S. Cacev T, et al. Among authors: spaventi r. J Cancer Res Clin Oncol. 2006 Mar;132(3):200-4. doi: 10.1007/s00432-005-0051-y. Epub 2005 Nov 8. J Cancer Res Clin Oncol. 2006. PMID: 16283382

3

High c-erbB-2 protein level in colorectal adenocarcinomas correlates with clinical parameters.

Kapitanovic S, Spaventi R, Poljak L, Kapitanovic M, Pavelic ZP, Gluckman JL, Spaventi S, Pavelic K. Kapitanovic S, et al. Among authors: spaventi s, spaventi r. Cancer Detect Prev. 1994;18(2):97-101. Cancer Detect Prev. 1994. PMID: 7912991

4

The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer.

Kapitanović S, Radosević S, Kapitanović M, Andelinović S, Ferencić Z, Tavassoli M, Primorać D, Sonicki Z, Spaventi S, Pavelic K, Spaventi R. Kapitanović S, et al. Among authors: spaventi s, spaventi r. Gastroenterology. 1997 Apr;112(4):1103-13. doi: 10.1016/s0016-5085(97)70120-3. Gastroenterology. 1997. PMID: 9097992

5

nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma.

Kapitanović S, Cacev T, Berković M, Popović-Hadzija M, Radosević S, Seiwerth S, Spaventi S, Pavelić K, Spaventi R. Kapitanović S, et al. Among authors: spaventi s, spaventi r. J Clin Pathol. 2004 Dec;57(12):1312-8. doi: 10.1136/jcp.2004.017954. J Clin Pathol. 2004. PMID: 15563674 Free PMC article.

6

Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.

Popović Hadzija M, Radosevic S, Kovacević D, Lukac J, Hadzija M, Spaventi R, Pavelić K, Kapitanović S. Popović Hadzija M, et al. Among authors: spaventi r. Mutat Res. 2004 Apr 14;548(1-2):61-73. doi: 10.1016/j.mrfmmm.2003.12.018. Mutat Res. 2004. PMID: 15063137

7

APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia.

Kapitanović S, Cacev T, Radosević S, Spaventi S, Spaventi R, Pavelić K. Kapitanović S, et al. Among authors: spaventi s, spaventi r. Exp Mol Pathol. 2004 Dec;77(3):193-200. doi: 10.1016/j.yexmp.2004.06.001. Exp Mol Pathol. 2004. PMID: 15507235

8

c-erbB-2/neu in colorectal carcinoma: a potential prognostic value?

Kapitanović S, Spaventi R, Kusić B, Pavelić K. Kapitanović S, et al. Among authors: spaventi r. Eur J Cancer. 1992;29A(1):170. doi: 10.1016/0959-8049(93)90606-g. Eur J Cancer. 1992. PMID: 1359899 No abstract available.

9

nm23-H1 gene expression in ovarian tumors--a potential tumor marker.

Kapitanovic S, Spaventi R, Vujsic S, Petrovic Z, Kurjak A, Pavelic ZP, Gluckman JL, Stambrook PJ, Pavelic K. Kapitanovic S, et al. Among authors: spaventi r. Anticancer Res. 1995 Mar-Apr;15(2):587-90. Anticancer Res. 1995. PMID: 7763042

10

Prognostic significance of transforming growth factor alpha TGF-alpha) in human lung carcinoma: an immunohistochemical study.

Pecur L, Kapitanovic S, Sonicki Z, Pavicic F, Spaventi S, Gluckman JL, Stambrook PJ, Pavelic ZP, Spaventi R, Pavelic K. Pecur L, et al. Among authors: spaventi s, spaventi r. Anticancer Res. 1994 Nov-Dec;14(6B):2839-43. Anticancer Res. 1994. PMID: 7872728 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters